Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of PHP-201 in Healthy Korean and Japanese Subjects
NCT03586908Phase 1Completed
- Sponsor
- pH Pharma Co., Ltd.
- Start
- Feb 2018
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of AMA0076 in Glaucoma and ocular hypertension, sponsored by pH Pharma Co., Ltd. Primary endpoints: Maximum Plasma Concentration at 1 week and Time to Maximum Plasma Concentration at 1 week. Started Feb 2018; status: completed.
02
Drugs
AMA0076
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT03586908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03586908.